Uterine Fibroids
Information
- Disease name
- Uterine Fibroids
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04126824 | Active, not recruiting | Early Phase 1 | Effect of Addition of Steroids on Duration of Analgesia | January 6, 2022 | February 2026 |
| NCT03271489 | Active, not recruiting | Phase 3 | Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women | January 4, 2017 | July 11, 2024 |
| NCT03194646 | Active, not recruiting | Phase 3 | Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids | June 30, 2017 | June 30, 2024 |
| NCT02100904 | Active, not recruiting | Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry | May 2014 | September 2025 | |
| NCT00156208 | Completed | Phase 3 | Safety of Treatment of Uterine Fibroids With Asoprisnil | April 2004 | December 2006 |
| NCT00159328 | Completed | Phase 4 | Efficacy Study of Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Large Fibroids | March 2003 | December 2006 |
| NCT00067249 | Completed | Women's Use of Alternative Medicine: A Multiethnic Study | April 2001 | September 2001 | |
| NCT00166270 | Completed | N/A | MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids | January 2005 | January 2009 |
| NCT04177693 | Completed | Phase 1 | Pharmacokinetics and Hepatic Safety of EGCG | November 24, 2020 | January 31, 2022 |
| NCT04091529 | Completed | N/A | Tailored Radiofrequency Ablation of Uterine Myomas | March 1, 2017 | March 31, 2019 |
| NCT00295217 | Completed | Phase 3 | MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Software V4.2 Validation | February 2006 | October 2006 |
| NCT00339547 | Completed | Risk Factors for Uterine Fibroids: A Case Control Study | November 1, 1995 | July 23, 2019 | |
| NCT00354471 | Completed | Uterine Artery Embolization for Symptomatic Fibroids | |||
| NCT00365989 | Completed | Phase 3 | MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication | October 2006 | August 2008 |
| NCT03886220 | Completed | Phase 4 | A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women | April 12, 2019 | April 28, 2021 |
| NCT03751124 | Completed | Phase 3 | Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids | October 16, 2018 | November 18, 2021 |
| NCT00579475 | Completed | Phase 1 | The Effect of Mifepristone on Uterine Fibroids and Breast Tissue | November 2004 | June 2007 |
| NCT03411980 | Completed | Phase 1 | Pharmacokinetics and Safety of Vilaprisan in Renal Impairment | February 2, 2018 | February 6, 2019 |
| NCT00628901 | Completed | Phase 4 | A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) | January 2006 | January 2011 |
| NCT03317795 | Completed | Phase 4 | Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids | November 14, 2017 | December 28, 2020 |
| NCT00712595 | Completed | Phase 2/Phase 3 | Mifepristone for Treatment of Uterine Fibroids | January 2007 | March 2009 |
| NCT00731341 | Completed | N/A | Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata | July 2008 | February 2009 |
| NCT03070951 | Completed | Phase 3 | Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids | May 23, 2017 | October 4, 2020 |
| NCT03070899 | Completed | Phase 3 | Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids | April 20, 2017 | April 12, 2021 |
| NCT00776074 | Completed | Phase 2 | A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids. | June 2006 | July 2007 |
| NCT02925494 | Completed | Phase 3 | An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids | September 14, 2016 | March 22, 2019 |
| NCT00837161 | Completed | Phase 1/Phase 2 | Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids | January 2009 | December 2010 |
| NCT02844920 | Completed | Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of Fibroids | July 20, 2017 | August 27, 2018 | |
| NCT02835391 | Completed | N/A | PerClot Compared to Usual Care in Gynaecology Procedures | November 2015 | August 2017 |
| NCT00874029 | Completed | N/A | Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids | March 2009 | March 2014 |
| NCT02831556 | Completed | Point of Care 3D Ultrasound for Various Applications: A Pilot Study | July 2016 | August 31, 2022 | |
| NCT00882258 | Completed | Phase 2 | Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids | March 2006 | March 2007 |
| NCT00886873 | Completed | Phase 2/Phase 3 | Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids | May 2008 | May 2009 |
| NCT00897897 | Completed | N/A | Therapeutic Magnetic Resonance Imaging (MRI)-Guided High Intensity Focused Ultrasound (HIFU) Ablation of Uterine Fibroids | April 2009 | December 2009 |
| NCT00958334 | Completed | Phase 2 | Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003 | September 7, 2006 | October 15, 2008 |
| NCT02819609 | Completed | Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids | November 2014 | January 2015 | |
| NCT00979342 | Completed | N/A | Comparative Sedation Study of the MyoSure Hysteroscopic Tissue Removal System | November 2009 | July 2010 |
| NCT00995878 | Completed | Phase 4 | The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids. | April 29, 2010 | December 2017 |
| NCT02691494 | Completed | Phase 3 | Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study) | February 3, 2016 | January 23, 2019 |
| NCT01092988 | Completed | N/A | A Clinical Study to Evaluate Safety of the ExAblate 2100 UF V2 System in the Treatment of Symptomatic Uterine Fibroids | March 2010 | February 2012 |
| NCT02655237 | Completed | Phase 3 | A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids | March 5, 2016 | September 25, 2017 |
| NCT01142791 | Completed | N/A | Safety Study of ExAblate for the Treatment of Uterine Fibroids | May 2010 | April 2012 |
| NCT01152112 | Completed | N/A | HOME Study: Hysteroscopic Office Myomectomy Evaluation | June 2010 | June 2013 |
| NCT01156857 | Completed | Phase 3 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata | July 2010 | February 2012 |
| NCT02655224 | Completed | Phase 3 | A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine Fibroids | March 26, 2016 | May 19, 2017 |
| NCT01229826 | Completed | Magnetic Resonance Elastography (MRE) of Uterine Fibroids | October 2010 | June 2015 | |
| NCT01252069 | Completed | Phase 3 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study) | January 2011 | January 2014 |
| NCT01285960 | Completed | N/A | ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids | May 2012 | April 2016 |
| NCT02654054 | Completed | Phase 3 | Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women | December 22, 2015 | December 12, 2018 |
| NCT01369758 | Completed | N/A | MyoSure Hysteroscopic Tissue Removal System Registry Study | November 2010 | May 2013 |
| NCT01377519 | Completed | N/A | Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids | June 2011 | December 2012 |
| NCT01388907 | Completed | Phase 4 | Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery | May 2006 | June 2011 |
| NCT01441635 | Completed | Phase 2 | Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids | September 8, 2011 | May 17, 2014 |
| NCT01451424 | Completed | Phase 2 | Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids | February 2012 | January 2013 |
| NCT01452659 | Completed | Phase 2 | Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids | October 2011 | September 2012 |
| NCT02472184 | Completed | N/A | Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy | October 2015 | March 2017 |
| NCT02470741 | Completed | Phase 4 | Pilot of Letrozole for Uterine Myomas | July 2015 | December 2017 |
| NCT02323646 | Completed | Phase 2 | Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids | February 12, 2015 | April 6, 2017 |
| NCT01563783 | Completed | N/A | Post Market TRUST Study | December 2012 | June 2022 |
| NCT01588899 | Completed | N/A | China Clinical Trial for Therapeutic MR-HIFU Ablation of Uterine Fibroids | May 2012 | May 2015 |
| NCT01629563 | Completed | Phase 3 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata | June 2012 | January 2015 |
| NCT01631903 | Completed | Phase 2 | Extension of Study ZPV-200 | September 2012 | April 2014 |
| NCT02301897 | Completed | Phase 2 | A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids | March 16, 2015 | June 2, 2017 |
| NCT01642472 | Completed | Phase 3 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata | July 2012 | April 2015 |
| NCT02192606 | Completed | N/A | Does 3D Laparoscopy Improve Vaginal Cuff Suture Time? | November 2013 | September 2016 |
| NCT01739621 | Completed | Phase 2 | Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200 | September 2012 | April 2014 |
| NCT01750008 | Completed | N/A | Laparoscopic Uterine Sparing Techniques Outcomes and Reinterventions | November 2012 | June 2018 |
| NCT01817530 | Completed | Phase 2 | Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF) | April 8, 2013 | December 2015 |
| NCT02086370 | Completed | N/A | Prophylactic Salpingectomy for the Prevention of the Ovarian Cancer: Comparison Between Surgical Techniques | March 2014 | April 2015 |
| NCT01840124 | Completed | N/A | Uterine Leiomyoma Treatment With Radiofrequency Ablation | July 2013 | January 2020 |
| NCT02086279 | Completed | N/A | AMH Levels Change During Treatment With GnRh Agonist | March 2014 | November 2014 |
| NCT01852734 | Completed | N/A | Uterine Fibroid Embolization- Long Term Follow up and Technical Perspectives | November 2013 | April 2016 |
| NCT01865929 | Completed | N/A | Minimally Invasive Benign Hysterectomy | January 2010 | June 2013 |
| NCT01936493 | Completed | Biologic Predictors of Leiomyoma Treatment Outcomes | August 2009 | May 26, 2015 | |
| NCT01992718 | Completed | Early Phase 1 | What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography | November 2013 | March 2018 |
| NCT02059954 | Completed | N/A | Vaginal vs. Laparoscopic Hysterectomy | January 2014 | September 2017 |
| NCT00150644 | Completed | Phase 2 | A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy | July 2003 | May 2005 |
| NCT00152256 | Completed | Phase 3 | A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids | September 2003 | February 2005 |
| NCT00156156 | Completed | Phase 3 | Study of Asoprisnil in the Treatment of Uterine Fibroids. | November 2004 | February 2007 |
| NCT06055114 | Not yet recruiting | Study on Vaginal Microecology and Cervical Local Immune Function in Patients With Uterine Fibroids of Childbearing Age | October 9, 2023 | October 9, 2026 | |
| NCT05448365 | Recruiting | Phase 3 | Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid | July 1, 2022 | October 1, 2025 |
| NCT05078307 | Recruiting | N/A | Evaluation of a Hysteroscopic Method With Vaporization in the Hysteroscopic Treatment of Submucosal Uterine Fibroids | September 25, 2021 | May 17, 2024 |
| NCT05862272 | Recruiting | Phase 3 | A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis | August 14, 2023 | September 2030 |
| NCT02914704 | Recruiting | N/A | Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU) | January 2016 | December 2025 |
| NCT05620355 | Recruiting | Phase 3 | Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids. | December 16, 2022 | March 2025 |
| NCT03948789 | Recruiting | Phase 3 | Phase III Study of MR-Guided Focused Ultrasound Surgery for the Treatment of Uterine Fibroids Compared to Myomectomy | July 15, 2020 | June 2025 |
| NCT00496067 | Terminated | N/A | Uterine Artery Occlusion for Fibroid Related Bleeding | April 2007 | December 2009 |
| NCT01834703 | Terminated | N/A | Uterine Artery Embolization(UAE) Versus High-Intensity-Focused-Ultrasound(HIFU) for Treatment of Uterine Fibroids | May 2009 | December 2015 |
| NCT00232713 | Terminated | Uterine Fibroid Pregnancy Registry | December 2005 | December 2005 | |
| NCT05026502 | Terminated | A Study to Assess Patient-Reported Quality of Life and Effectiveness on Control of Bleeding in Adult Participants With Heavy Menstrual Bleeding Due to Uterine Fibroids Taking Oral Oriahnn Capsules | October 5, 2021 | August 30, 2022 | |
| NCT01539187 | Terminated | N/A | Fibroid Ablation Study - Large Fibroids | June 2012 | June 2014 |
| NCT01504308 | Terminated | Phase 2/Phase 3 | Sonalleve Fibroid Ablation Pivotal Clinical Trial for MR-HIFU of Uterine Fibroids | May 2012 | March 2016 |
| NCT01226290 | Terminated | N/A | Fibroid Ablation Study | January 2011 | March 2014 |
| NCT01140555 | Terminated | N/A | A Pilot Study to Determine Optimal Procedure Steps to Obtain and Maintain Uterine Artery Occlusion With the D-UAO Device | April 2010 | July 2010 |
| NCT01069120 | Terminated | Phase 3 | Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids | April 2009 | August 2009 |
| NCT01786226 | Terminated | Phase 2/Phase 3 | Mifepristone to Treat Uterine Fibroids | March 2010 | March 2012 |
| NCT02811159 | Terminated | Phase 2 | An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids | July 26, 2016 | May 4, 2017 |
| NCT00958893 | Terminated | Phase 2 | An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext | June 2008 | August 2009 |
| NCT01675011 | Terminated | N/A | Embozene Microspheres for Uterine Fibroid Embolization (UFE) | August 2012 | December 2013 |
| NCT00853567 | Terminated | Phase 3 | Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids | February 2009 | August 2009 |
| NCT01842789 | Terminated | N/A | Post Market Evaluation of Acessa With TAG | April 2013 | February 2016 |
| NCT00785356 | Terminated | Phase 3 | Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids | October 2008 | August 2009 |
| NCT01998854 | Terminated | Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation | February 2013 | January 2015 | |
| NCT00737282 | Terminated | Phase 3 | Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids | October 2008 | August 2009 |
| NCT00735553 | Terminated | Phase 3 | Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids | August 2008 | August 2009 |
| NCT03240523 | Terminated | Phase 3 | Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids | July 31, 2017 | October 25, 2021 |
| NCT00702702 | Terminated | Phase 3 | Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids | June 2008 | August 2009 |
| NCT03400943 | Terminated | Phase 3 | Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3) | January 17, 2018 | April 6, 2022 |
| NCT00683917 | Terminated | Phase 2 | Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids | May 2008 | August 2009 |
| NCT03400956 | Terminated | Phase 3 | Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4) | January 24, 2018 | June 30, 2021 |
| NCT00584207 | Terminated | Early Phase 1 | Radiofrequency Ablation of Uterine Fibroids | March 2004 | July 2008 |
| NCT01555073 | Terminated | Phase 4 | Preemptive Analgesia Following Uterine Artery Embolization | October 2011 | October 2013 |
| NCT02425878 | Terminated | Phase 3 | Ulipristal Acetate 10 mg and Asisted Reproduction | October 19, 2015 | May 31, 2016 |
| NCT00496080 | Terminated | N/A | Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related Bleeding | June 2007 | October 2010 |
| NCT00163930 | Unknown status | Post-Operative Pain Management in Patients Undergoing Uterine Artery Embolisation for Symptomatic Leiomyomata | January 2005 | December 2007 | |
| NCT02086344 | Unknown status | N/A | Ovarian Reserve Modification After Lps Hysterectomy With Bilateral Salpingectomy | February 2014 | December 2016 |
| NCT02283502 | Unknown status | Phase 1 | Clinical Test of the MRgHIFU System on Uterine Fibroids | September 2014 | May 2015 |
| NCT01635452 | Unknown status | A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids | May 2012 | March 2016 | |
| NCT02440750 | Unknown status | Phase 4 | Endometrial Preparation Before Operative Hysteroscopy in Premenopausal Women | June 2016 | June 2017 |
| NCT02748460 | Unknown status | Non-interventional Study to Evaluate Long Term Safety, Prescription Management Patterns of Esmya in a Long Term Setting | December 2015 | December 2022 | |
| NCT00860002 | Unknown status | The Benefits and Limits of Laparoscopic Surgery for Uterine Fibroids | January 2009 | December 2014 | |
| NCT02884960 | Unknown status | N/A | Safety and Efficacy of Embozene Microspheres for Uterine Fibroid Embolization | October 2016 | October 2018 |
| NCT02942537 | Unknown status | Phase 2/Phase 3 | Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave Treatment | January 23, 2017 | February 2020 |
| NCT03500367 | Unknown status | Phase 4 | Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis | January 1, 2018 | December 31, 2022 |
| NCT03586947 | Unknown status | N/A | Association Between Vitamin D and the Risk of Uterine Fibroids | September 15, 2018 | July 1, 2021 |
| NCT00277680 | Unknown status | N/A | Laparoscopic Occlusion of Uterine Vessels Compared to Uterine Fibroid Embolization for Treatment of Uterine Fibroids | December 2000 | April 2010 |
| NCT04400942 | Unknown status | Predictive Factors for Complete Myoma Resection During Hysteroscopic Myomectomy | January 1, 2015 | December 1, 2021 | |
| NCT04567095 | Withdrawn | A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Patients in Canada | October 31, 2020 | June 30, 2021 | |
| NCT04567589 | Withdrawn | A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Healthcare Professionals in Canada | September 30, 2020 | February 28, 2021 | |
| NCT00180739 | Withdrawn | Phase 4 | Safety Trial of Magnetic Resonance (MR) Guided Focused Ultrasound Surgery (FUS) in Women With Uterine Fibroids Wishing to Pursue Pregnancy in the Future | April 2004 | August 2005 |
| NCT03699176 | Withdrawn | Phase 3 | Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids | October 27, 2018 | December 25, 2019 |
| NCT00768742 | Withdrawn | N/A | Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study | September 2008 | November 2010 |
| NCT00874302 | Withdrawn | Phase 3 | Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms | ||
| NCT01328067 | Withdrawn | N/A | Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids | June 2011 | June 2017 |
| NCT01971060 | Withdrawn | N/A | a Study to Evaluate Adhesion Risk in Fertility Patients' Status Post Laparoscopic Myomectomy. | August 2013 | October 2014 |